BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
96 hedge funds and large institutions have $189M invested in Bellicum Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 46 increasing their positions, 13 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
52% less call options, than puts
Call options by funds: $654K | Put options by funds: $1.35M
Holders
96
Holding in Top 10
–
Calls
$654K
Puts
$1.35M
Top Buyers
| 1 | +$14.8M | |
| 2 | +$7.76M | |
| 3 | +$6.27M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$6.2M |
| 5 |
JPMorgan Chase & Co
New York
|
+$5.24M |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$2.3M | |
| 3 | -$1.83M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.06M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$696K |